ArticleChinese medical journal2026
Effect of TGFβ-ITGB6 feedback loop on liver metastasis in SMAD4 wild-type pancreatic cancer.
Article in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreatic cancer (PC) is among the deadliest digestive malignancies, with over half of patients showing liver metastases at diagnosis. Understanding the molecular mechanisms underlying PC liver metastasis is crucial for improving patient prognosis and extending survival. This study aimed to elucidate the role of integrin subunit beta 6 (ITGB6), a downstream target of transforming growth factor-β (TGFβ) signaling, in PC progression and metastasis, particularly focusing on its involvement in liver metastasis.
methodsFirst, ITGB6 was identified as a key TGFβ-pathway gene linked to liver metastasis in PC, with its enrichment further confirmed by SMAD family member 4 ( SMAD4 )-based subgroup analysis. A total of 37 paired clinical PC and adjacent normal tissue samples were obtained from patients who underwent surgical resection at Peking Union Medical College Hospital, and immunohistochemistry (IHC) was performed to evaluate ITGB6 expression and its correlation with clinicopathological features. In vitro assays, including cell proliferation, apoptosis detection, and cell migration and invasion assays, were conducted to evaluate the role of ITGB6 in PC cell behavior. A SMAD4 wild-type (WT) PC cell line stably overexpressing ITGB6 was established, and its in vivo role was assessed using subcutaneous and liver metastasis xenograft models. To explore the transcriptional regulation of ITGB6 by TGFβ, chromatin immunoprecipitation followed by quantitative polymerase chain reaction (ChIP-qPCR) and dual-luciferase reporter assays were performed. The effect of ITGB6-expressing PC cells on hepatic stellate cell (HSC) activation was evaluated using enzyme-linked immunosorbent assay (ELISA), Western blotting, and IHC. Finally, the therapeutic potential of targeting ITGB6 was preliminarily assessed using a monoclonal antibody intervention strategy.
resultsTGFβ upregulates ITGB6 expression through a SMAD4-dependent pathway. Elevated ITGB6 expression not only promotes the migration and invasion of PC cells but also activates HSCs, thereby establishing a fibrotic microenvironment favorable for metastatic colonization. In mouse models, administration of an ITGB6 monoclonal antibody significantly attenuated HSC activation and suppressed the formation of liver metastases. Therefore, ITGB6 serves as a key downstream effector of TGFβ-mediated metastasis and represents a promising therapeutic target for liver metastasis in PC.
conclusionsThe TGFβ-ITGB6 positive feedback axis plays a critical role in liver metastasis of SMAD4 WT PC, highlighting ITGB6 as a potential therapeutic target, especially for patients with intact SMAD4 function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.